Healthcare Spotlight

Spotlight 115: Fujifilm to Acquire Wako Pure Chemical Industries

FUJIFILM Corporation has announced that it approved the acquisition of a leading reagent manufacturer Wako Pure Chemical Industries. Fujifilm signed an agreement with Takeda Pharmaceutical whereby the Takeda group agreed to tender all of the common shares of Wako held by the Takeda group in the tender offer. Through the acquisition of Wako, Fujifilm will continue to expand its business by utilizing advanced technologies and competitive products, which Fujifilm and Wako possess. Fujifilm will be able to generate significant synergies in healthcare and highly functional materials businesses, by applying chemical synthesis technology, nano-technology and production technology developed by Fujifilm through its photographic film business. The acquisition of Wako will be a key milestone for Fujifilm’s future business growth. More


This website uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies.
%d bloggers like this: